PVT1 and prostate adenocarcinoma: Our data show correlation of high-PVT1-expression tumors with shorter disease-free patient survival in the 497-patients TCGA-PRAD cohort, confirming the results of a previous publication [21] with a 152-Chinese-patients cohort.